12-Month Efficacy of Advanced Hybrid Closed-Loop System in Adult Type 1 Diabetes Patients
Authors' conclusion
These findings underscore the effectiveness of AHCL systems in achieving and preserving optimal glycemic control in adults with T1D over a very long follow-up.
Study context
- Population
- Adults with T1D in a real-world clinical setting
- Participants
- 22 adults
- Outcome
- Achievement and maintenance of glycaemic control with AHCL
- Follow-up
- 12 months
Methodological detailsreal-world, single-group
- Real-world
- Single-group
Main finding
As reported in the abstract
Glycaemic control · 14 days to 12 months
- Rapid improvement in glycaemic control within 14 days of activating automatic mode, persisting for 12 months
Observational data: associations, not effects.
Original publication
12-Month Efficacy of Advanced Hybrid Closed-Loop System in Adult Type 1 Diabetes Patients. Diabetes Technol Ther. Published 14 November 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →